Impact of monitoring surgical prophylactic antibiotics and a computerized decision support system on antimicrobial use and antimicrobial resistance

American Journal of Infection Control

Volumn 44, Issue 9, 2016, Pages e145-e152

  Huh, Kyungmin ^a   Chung, Doo Ryeon ^a   Park, Hyo Jung ^b   Kim, Min Ji ^b   Lee, Nam Yong ^a   Ha, Young Eun ^a   Kang, Cheol In ^a   Peck, Kyong Ran ^a   Song, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

antibiotic prophylaxis; antimicrobial resistance; Antimicrobial stewardship; decision support system

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; MEROPENEM; PENICILLIN DERIVATIVE; QUINOLONE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL DECISION SUPPORT SYSTEM; COMPUTERIZED PROVIDER ORDER ENTRY; DRUG COST; DRUG MONITORING; DRUG USE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; LENGTH OF STAY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; TERTIARY CARE CENTER; TREND STUDY; BACTERIUM; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; DRUG UTILIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREOPERATIVE CARE; PREVALENCE; PROCEDURES; REGRESSION ANALYSIS; STANDARDS;

ANTIBIOTIC PROPHYLAXIS; BACTERIA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS; INTERRUPTED TIME SERIES ANALYSIS; PREOPERATIVE CARE; PREVALENCE; REGRESSION ANALYSIS; TERTIARY CARE CENTERS;

EID: 84960145459     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2016.01.025     Document Type: Article

References (38)

1. 1 Centers for Disease Control and Prevention, Antibiotic resistance threats in the United States. Available from http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf, 2013 Accessed April, 2013.
2. 2 Bantar, C., Sartori, B., Vesco, E., Heft, C., Saul, M., Salamone, F., et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 37 (2003), 180–186.
3. 3 Dellit, T.H., Owens, R.C., McGowan, J.E. Jr, Gerding, D.N., Weinstein, R.A., Burke, J.P., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44 (2007), 159–177.
4. 4 Fraser, G.L., Stogsdill, P., Dickens, J.D. Jr, Wennberg, D.E., Smith, R.P. Jr, Prato, B.S., Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 157 (1997), 1689–1694.
5. 5 Solomon, D.H., Van Houten, L., Glynn, R.J., Baden, L., Curtis, K., Schrager, H., et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 161 (2001), 1897–1902.
6. 6 Carling, P., Fung, T., Killion, A., Terrin, N., Barza, M., Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 24 (2003), 699–706.
7. 7 Belongia, E.A., Knobloch, M.J., Kieke, B.A., Davis, J.P., Janette, C., Besser, R.E., Impact of statewide program to promote appropriate antimicrobial drug use. Emerg Infect Dis 11 (2005), 912–920.
8. 8 Girotti, M.J., Fodoruk, S., Irvine-Meek, J., Rotstein, O.D., Antibiotic handbook and pre-printed perioperative order forms for surgical antibiotic prophylaxis: do they work?. Can J Surg 33 (1990), 385–388.
9. 9 Burke, J.P., Antibiotic resistance—squeezing the balloon?. JAMA 280 (1998), 1270–1271.
10. 10 Abramson, E.L., Kaushal, R., Computerized provider order entry and patient safety. Pediatr Clin North Am 59 (2012), 1247–1255.
11. 11 Williams, S.C., Schmaltz, S.P., Morton, D.J., Koss, R.G., Loeb, J.M., Quality of care in U.S. hospitals as reflected by standardized measures, 2002-2004. N Engl J Med 353 (2005), 255–264.
12. 12 Mainz, J., Hansen, A.M., Palshof, T., Bartels, P.D., National quality measurement using clinical indicators: the Danish National Indicator Project. J Surg Oncol 99 (2009), 500–504.
13. 13 Department of Health Policy and Management, Seoul National University College of Medicine, Result of preliminary implementation of clinical performance indicators in national hospital evaluation program. 2007, Seoul National University College of Medicine, Seoul, Republic of Korea.
14. 14 Health Insurance Review & Assessment Service, Hospital evaluation information. Available from http://www.hira.or.kr/rec_infopub.hospinfo.do?method=listDiagEvl&pgmid=HIRAA030004000000 Accessed October 10, 2012.
15. 15 WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment, 2012. Oslo, Norway, 2011.
16. 16 Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. 2010, Clinical and Laboratory Standards Institute, Wayne (PA) M100-S20.
17. 17 Wagner, A.K., Soumerai, S.B., Zhang, F., Ross-Degnan, D., Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27 (2002), 299–309.
18. 18 Jamtvedt, G., Young, J.M., Kristoffersen, D.T., Thomson, O., Brien, M.A., Oxman, A.D., Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev(3), 2003 CD000259.
19. 19 Dellinger, E.P., Hausmann, S.M., Bratzler, D.W., Johnson, R.M., Daniel, D.M., Bunt, K.M., et al. Hospitals collaborate to decrease surgical site infections. Am J Surg 190 (2005), 9–15.
20. 20 Kim, E.S., Park, S.W., Lee, C.S., Gyung Kwak, Y., Moon, C., Kim, B.N., Impact of a national hospital evaluation program using clinical performance indicators on the use of surgical antibiotic prophylaxis in Korea. Int J Infect Dis 16 (2012), e187–92.
21. 21 van Kasteren, M.E., Kullberg, B.J., de Boer, A.S., Mintjes-de Groot, J., Gyssens, I.C., Adherence to local hospital guidelines for surgical antimicrobial prophylaxis: a multicentre audit in Dutch hospitals. J Antimicrob Chemother 51 (2003), 1389–1396.
22. 22 Miliani, K., L'Heriteau, F., Astagneau, P., INCISO Network Study Group. Non-compliance with recommendations for the practice of antibiotic prophylaxis and risk of surgical site infection: results of a multilevel analysis from the INCISO Surveillance Network. J Antimicrob Chemother 64 (2009), 1307–1315.
23. 23 Choi, W.S., Song, J.Y., Hwang, J.H., Kim, N.S., Cheong, H.J., Appropriateness of antibiotic prophylaxis for major surgery in Korea. Infect Control Hosp Epidemiol 28 (2007), 997–1002.
24. 24 Meyer, E., Schwab, F., Pollitt, A., Bettolo, W., Schroeren-Boersch, B., Trautmann, M., Impact of a change in antibiotic prophylaxis on total antibiotic use in a surgical intensive care unit. Infection 38 (2010), 19–24.
25. 25 Shojania, K.G., Yokoe, D., Platt, R., Fiskio, J., Ma'luf, N., Bates, D.W., Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial. J Am Med Inform Assoc 5 (1998), 554–562.
26. 26 Pestotnik, S.L., Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med, 124, 1996, 884.
27. 27 Evans, R.S., Pestotnik, S.L., Classen, D.C., Clemmer, T.P., Weaver, L.K., Orme, J.F. Jr, et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 338 (1998), 232–238.
28. 28 Paul, M., Andreassen, S., Tacconelli, E., Nielsen, A.D., Almanasreh, N., Frank, U., et al. Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. J Antimicrob Chemother 58 (2006), 1238–1245.
29. 29 Filice, G.A., Drekonja, D.M., Thurn, J.R., Rector, T.S., Hamann, G.M., Masoud, B.T., et al. Use of a computer decision support system and antimicrobial therapy appropriateness. Infect Control Hosp Epidemiol 34 (2013), 558–565.
30. 30 Samore, M.H., Bateman, K., Alder, S.C., Hannah, E., Donnelly, S., Stoddard, G.J., et al. Clinical decision support and appropriateness of antimicrobial prescribing: a randomized trial. JAMA 294 (2005), 2305–2314.
31. 31 Thursky, K.A., Buising, K.L., Bak, N., Macgregor, L., Street, A.C., Macintyre, C.R., et al. Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit. Int J Qual Health Care 18 (2006), 224–231.
32. 32 Kawamoto, K., Houlihan, C.A., Balas, E.A., Lobach, D.F., Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ, 330, 2005, 765.
33. 33 Stone, S.P., Fuller, C., Savage, J., Cookson, B., Hayward, A., Cooper, B., et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ, 344, 2012, e3005.
34. 34 Pires dos Santos, R., Jacoby, T., Pires Machado, D., Lisboa, T., Gastal, S.L., Nagel, F.M., et al. Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates. Infect Control Hosp Epidemiol 32 (2011), 584–590.
35. 35 Kaier, K., Frank, U., Hagist, C., Conrad, A., Meyer, E., The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum beta-lactamase-producing strains: a time-series analysis. J Antimicrob Chemother 63 (2009), 609–614.
36. 36 Lafaurie, M., Porcher, R., Donay, J.L., Touratier, S., Molina, J.M., Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study. J Antimicrob Chemother 67 (2012), 1010–1015.
37. 37 Kim, J.Y., Sohn, J.W., Park, D.W., Yoon, Y.K., Kim, Y.M., Kim, M.J., Control of extended-spectrum β-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use. J Antimicrob Chemother 62 (2008), 416–421.
38. 38 Bratzler, D.W., Dellinger, E.P., Olsen, K.M., Perl, T.M., Auwaerter, P.G., Bolon, M.K., et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 70 (2013), 195–283.